Dr. Adam Kaplin completed his undergraduate training at Yale University and his MD and PhD training at the Johns Hopkins School of Medicine. His research training experience includes having trained in the labs of two Nobel Laureates, and completed his PhD and postdoctoral training in the Lab of Solomon Snyder, MD, who was the 2005 recipient of the National Medal of Science (the highest science honor in the United States).
Dr. Kaplin is the Chief Psychiatric Consultant to the Johns Hopkins Multiple Sclerosis and Transverse Myelitis Centers, where he is an integral member of the clinical and research endeavors at these Centers of Excellence. Dr. Kaplin investigates the biological basis of the effects of the immune system on mood regulation and cognition, and he provides neuropsychiatric care to patients afflicted with such comorbidities. His research is focused on understanding the biological basis of depression and dementia and discovering new ways to diagnose prognosticate and treat these diseases.
More recently Dr. Kaplin has also been involved in helping to develop and apply technological innovations to improve patient care and clinical research. He is the inventor and co-developer of www.mood247.com, an automated mood tracking technology that also serves as a personalized, patient-controlled electronic health diary.
Dr. Kaplin is on the board of medical advisors to the Montel Williams MS Foundation, Cody Unser First Step Foundation, Nancy Davis MS Foundation and Center Without Walls, and Johns Hopkins Multiple Sclerosis and Transverse Myelitis Center’s Project RESTORE. He is also medical advisor to Remedy Health Media, and Anthrotronix Inc. He has presented his work through published articles in premier scientific journals, through talks and seminars at national and international conferences.